Rocket Pharmaceuticals, Inc. (RCKT)
USD 11.74
(-1.51%)
USD 11.74
(-1.51%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -194.91 Million | -178.14 Million | -121.16 Million | -74.64 Million | -64.66 Million | -53.78 Million |
| Net Income | -245.59 Million | -221.86 Million | -169.06 Million | -139.7 Million | -77.27 Million | -74.51 Million |
| Depreciation & Amortization | 7.09 Million | 6.26 Million | 5.37 Million | 1.14 Million | 426 Thousand | 330 Thousand |
| Deferred income taxes | -10.14 Million | - | 3.14 Million | 999 Thousand | -1.06 Million | -484 Thousand |
| Stock-based compensation | 39.4 Million | 31 Million | 29.23 Million | 18.56 Million | 13.37 Million | 13.6 Million |
| Change in working capital | 13.45 Million | 6.07 Million | -3.38 Million | 15.02 Million | -3.72 Million | 4.38 Million |
| Other non-cash items | 864 Thousand | 370 Thousand | 13.53 Million | 29.32 Million | 3.6 Million | 2.89 Million |
| Investing Cash Flow | -98.06 Million | -69.32 Million | 18.85 Million | -96.59 Million | -39.01 Million | -5.27 Million |
| Investments in PPE | -16.47 Million | -8.61 Million | -7.71 Million | -29.05 Million | -23.26 Million | -1.45 Million |
| Acquisitions | 36 Thousand | 42.72 Million | 95 Thousand | 8.45 Million | 15.74 Thousand | 76.34 Million |
| Investment purchases | -390.92 Million | -376.32 Million | -245.87 Million | -209.34 Million | -184.29 Million | -141.08 Million |
| Sales/Maturities of investments | 309.32 Million | 272.89 Million | 272.44 Million | 141.81 Million | 168.55 Million | 61.27 Million |
| Other Investing Activities | -36 Thousand | -103.69 Thousand | -95 Thousand | -8.45 Million | -15.74 Thousand | -356 Thousand |
| Financing Cash Flow | 208.4 Million | 155.28 Million | 37.68 Thousand | 282.98 Million | 177.79 Million | 153.5 Million |
| Debt repayment | -139 Thousand | -172 Thousand | -201 Thousand | -5.55 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -47 Thousand | - | -72 Thousand | 726 Thousand | -668 Thousand |
| Common Stock Issuance | 208.39 Million | 154.7 Million | 37.68 Million | 281.35 Million | 178.1 Million | 154.02 Million |
| Other Financing Activities | 146 Thousand | 975 Thousand | 37.68 Thousand | 12.82 Million | -1.03 Million | 148 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 10.14 Million | 9.67 Million | -4.82 Million | 11.01 Million | -2.72 Million | 5.89 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -10.14 Million | -3.59 Million | 1.44 Million | 4.01 Million | -1 Million | -1.5 Million |
| Cash at beginning of period | 141.85 Million | 234.03 Million | 298.66 Million | 186.9 Million | 112.79 Million | 18.34 Million |
| Cash at end of period | 57.27 Million | 141.85 Million | 234.03 Million | 298.66 Million | 186.9 Million | 112.79 Million |
| Capital Expenditure | -16.47 Million | -8.61 Million | -7.71 Million | -29.05 Million | -23.26 Million | -1.45 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -84.58 Million | -92.18 Million | -64.62 Million | 111.75 Million | 74.11 Million | 94.44 Million |
| Free Cash Flow | -211.38 Million | -186.76 Million | -128.87 Million | -103.69 Million | -87.93 Million | -55.24 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -69.64 Million | -62.05 Million | -59.66 Million | -245.59 Million | -61.89 Million | -65.7 Million |
| Depreciation & Amortization | 2.33 Million | 2.25 Million | 1.93 Million | 7.09 Million | 1.75 Million | 1.73 Million |
| Deferred income taxes | - | - | -12.46 Million | -10.14 Million | 12.46 Million | - |
| Stock-based compensation | 11.33 Million | 10.25 Million | 9.93 Million | 39.4 Million | 10.31 Million | 10.24 Million |
| Change in working capital | 4.33 Million | -4.58 Million | 21.52 Million | 13.45 Million | -5.94 Million | 5.34 Million |
| Other non-cash items | 13.8 Million | 12 Million | 9.39 Million | 864 Thousand | -13.84 Million | -2.48 Million |
| Investing Cash Flow | 55.62 Million | 35.03 Million | -140.8 Million | -98.06 Million | 48.25 Million | 31.2 Million |
| Investments in PPE | -1.93 Million | -2.03 Million | -4.64 Million | -16.47 Million | -4.65 Million | -4.14 Million |
| Acquisitions | - | - | 81.23 Thousand | 36 Thousand | -52.9 Thousand | -35.32 Thousand |
| Investment purchases | -38.57 Million | -63.94 Million | -208.5 Million | -390.92 Million | -13.48 Million | -72.89 Million |
| Sales/Maturities of investments | 96.12 Million | 101.01 Million | 72.34 Million | 309.32 Million | 66.39 Million | 108.25 Million |
| Other Investing Activities | - | 37.06 Thousand | -81.23 Thousand | -36 Thousand | 52.9 Thousand | 35.32 Thousand |
| Financing Cash Flow | 1.55 Million | 1.21 Million | 391 Thousand | 208.4 Million | 189.48 Million | 182 Thousand |
| Debt repayment | -29 Thousand | -27 Thousand | -109 Thousand | -139 Thousand | -35 Thousand | -37 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 1.53 Million | 1.18 Million | 391 Thousand | 208.39 Million | 189.48 Million | 182 Thousand |
| Other Financing Activities | - | 1184.00 | 109 Thousand | 146 Thousand | 35 Thousand | 37 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | -2.41 Million | 17.89 Million | 10.14 Million | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 4.33 Million | -4.58 Million | 3.63 Million | -10.14 Million | -5.94 Million | 5.34 Million |
| Cash at beginning of period | 35.27 Million | 55.9 Million | 227.02 Million | 141.85 Million | 46.43 Million | 65.91 Million |
| Cash at end of period | 38.6 Million | 35.27 Million | 57.27 Million | 57.27 Million | 227.02 Million | 46.43 Million |
| Capital Expenditure | -1.93 Million | -2.03 Million | -4.64 Million | -16.47 Million | -4.65 Million | -4.14 Million |
| Effect of forex changes on cash | - | - | 166.74 Million | - | -166.74 Million | - |
| Net cash flow / Change in cash | 3.33 Million | -20.62 Million | -169.75 Million | -84.58 Million | 180.59 Million | -19.48 Million |
| Free Cash Flow | -55.78 Million | -58.91 Million | -33.98 Million | -211.38 Million | -61.8 Million | -55.01 Million |
STG
3390
8069
PHT
CSIQ
MEGASTAR